These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 11904239

  • 1. The costs of epilepsy in Italy: a prospective cost-of-illness study in referral patients with disease of different severity.
    Tetto A, Manzoni P, Millul A, Beghi E, Garattini L, Tartara A, Avanzini G, Osservatorio Regionale per l'Epilessia (OREp).
    Epilepsy Res; 2002 Feb; 48(3):207-16. PubMed ID: 11904239
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The costs of childhood epilepsy in Italy: comparative findings from three health care settings.
    Guerrini R, Battini R, Ferrari AR, Veggiotti P, Besana D, Gobbi G, Pezzani M, Berta E, Tetto A, Beghi E, Monticelli ML, Tediosi F, Garattini L, Russo S, Rasmini P, Amadi A, Quarti P, Fabrizzi R, Epilepsy Collaborative Study Group.
    Epilepsia; 2001 May; 42(5):641-6. PubMed ID: 11380572
    [Abstract] [Full Text] [Related]

  • 4. A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy.
    Luoni C, Canevini MP, Capovilla G, De Sarro G, Galimberti CA, Gatti G, Guerrini R, La Neve A, Mazzucchelli I, Rosati E, Specchio LM, Striano S, Tinuper P, Perucca E.
    Epilepsia; 2015 Jul; 56(7):1162-73. PubMed ID: 26046371
    [Abstract] [Full Text] [Related]

  • 5. A review of the costs of managing childhood epilepsy.
    Beghi E, Frigeni B, Beghi M, De Compadri P, Garattini L.
    Pharmacoeconomics; 2005 Jul; 23(1):27-45. PubMed ID: 15693726
    [Abstract] [Full Text] [Related]

  • 6. Side-effects of antiepileptic drugs: the economic burden.
    de Kinderen RJ, Evers SM, Rinkens R, Postulart D, Vader CI, Majoie MH, Aldenkamp AP.
    Seizure; 2014 Mar; 23(3):184-90. PubMed ID: 24315662
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Direct medical cost of children and adolescents epilepsy at a university setting in Croatia.
    Prpić I, Boban M, Skarpa-Prpić I, Jurjević A, Babić T, Fiket D.
    Coll Antropol; 2009 Jun; 33(2):503-8. PubMed ID: 19662770
    [Abstract] [Full Text] [Related]

  • 9. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany.
    Strzelczyk A, Haag A, Reese JP, Nickolay T, Oertel WH, Dodel R, Knake S, Rosenow F, Hamer HM.
    Epilepsy Behav; 2013 Jun; 27(3):433-8. PubMed ID: 23591262
    [Abstract] [Full Text] [Related]

  • 10. Direct medical costs of refractory epilepsy incurred by three different treatment modalities: a prospective assessment.
    Boon P, D'Havé M, Van Walleghem P, Michielsen G, Vonck K, Caemaert J, De Reuck J.
    Epilepsia; 2002 Jan; 43(1):96-102. PubMed ID: 11879393
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cost-of-illness of epilepsy in Italy. Data from a multicentre observational study (Episcreen).
    Berto P, Tinuper P, Viaggi S.
    Pharmacoeconomics; 2000 Feb; 17(2):197-208. PubMed ID: 10947342
    [Abstract] [Full Text] [Related]

  • 14. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
    Hong Z, Qu B, Wu XT, Yang TH, Zhang Q, Zhou D.
    Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of costs of epilepsy using an electronic practice management software in Germany.
    Noda AH, Hermsen A, Berkenfeld R, Dennig D, Endrass G, Kaltofen J, Safavi A, Wiehler S, Carl G, Meier U, Elger CE, Menzler K, Knake S, Rosenow F, Strzelczyk A.
    Seizure; 2015 Mar; 26():49-55. PubMed ID: 25799902
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antiepileptic Drug Titration and Related Health Care Resource Use and Costs.
    Fishman J, Kalilani L, Song Y, Swallow E, Wild I.
    J Manag Care Spec Pharm; 2018 Sep; 24(9):929-938. PubMed ID: 29486142
    [Abstract] [Full Text] [Related]

  • 19. Uptake and costs of care for epilepsy: findings from a U.K. regional study.
    Jacoby A, Buck D, Baker G, McNamee P, Graham-Jones S, Chadwick D.
    Epilepsia; 1998 Jul; 39(7):776-86. PubMed ID: 9670907
    [Abstract] [Full Text] [Related]

  • 20. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
    Arzimanoglou A, Kulak I, Bidaut-Mazel C, Baldy-Moulinier M.
    Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.